
    
      A randomized placebo controlled clinical trial will be conducted in Rajaie Cardiovascular
      Center in Tehran, Iran. After review of the inclusion and exclusion criteria and explanation
      of the design of the study, written consent form will be completed. The participants are 40
      eligible patients, aged 20-75 years. Intervention group will be received 25 mL/d extra-virgin
      olive oil and control group will be received 25 mL/d refined olive oil for 6 weeks. Fasting
      blood sample will be taken to measure lipid profile, liver enzymes and inflammatory markers
      (Interleukine-6 [IL-6] and Interleukine-10 [IL-10] and C-Reactive Protein [CRP]).
    
  